超强增强剂概况显示ThPOK/ZBTB7B,一个CD4细胞系承诺因子,作为一个主调节者,限制乳腺癌细胞以光线非迁移型表型
Camila D Arcuschin1,2, Kamin Kahrizi3,4, Rosalyn W Sayaman5
1Departamento de Fisiología, Biología Molecular y Celular, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Ciudad Universitaria, Buenos Aires, Argentina.
Cellular and molecular life sciences : CMLS
|November 13, 2025
概括
研究人员确定了ThPOK (T-helper诱导的Poxvirus和指/POZ/Krüppel类因子) 作为抑制乳腺癌转移的关键调节器. 这一发现为预防癌症扩散提供了新的治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 转移性乳腺癌仍然是一个重大的临床挑战.
- 了解乳腺癌的进展和识别转移抑制剂对于治疗开发至关重要.
- 转录失调,特别是涉及超级增强剂 (SE),在癌症进展中起着关键作用.
研究的目的:
- 通过分析超强增强器景观和主调节器活动来识别新的乳腺癌依赖性.
- 调查T-助手诱导的Poxvirus和指/POZ/Krüppel-like因子 (ThPOK) 在乳腺癌转移中的作用.
主要方法:
- 超强增强剂 (SE) 景观的综合分析与乳腺癌细胞系中主调节器活动推断.
- 在细胞系中操纵ThPOK表达水平,以评估其功能影响.
- 分析ThPOK对参与上皮层-介质细胞转换 (EMT),WNT/β-catenin信号传递和TGFβ通路的基因的影响.
主要成果:
- ThPOK (ZBTB7B) 被确定为经常与乳腺癌中SE相关的主调节器.
- 在光线乳腺癌中,ThPOK的表达率较高,在基底亚型中则降低.
- ThPOK抑制了驱动上皮层-介质细胞转换 (EMT) 的基因,WNT/β-catenin标,以及前转移性TGFβ通路,将细胞限制在上皮层表型上.
结论:
- ThPOK作为一个主转录因子,限制乳腺癌细胞获得转移性特征.
- ThPOK的抑制功能对于维持表皮表型和抑制转移潜力至关重要.
- 准ThPOK或其调节途径可能为预防乳腺癌转移提供新的治疗策略.
相关概念视频
Master Transcription Regulators
7.6K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.6K
Abnormal Proliferation
5.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K


